Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-14

Clinical Trial Update: Trial of EXenatide in Acute Ischaemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for exenatide in acute ischemic stroke is reported, with status and details currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Neuroscience Trials Australia | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN